Get started

Price-action

Daily Nifty Levels | Nifty Support & resistance India 20221-South African Stocks End at Near 3-Month Low 2-Oil Prices Extend the Decline 3-Annual inflation rate in India accelerated for a 5th straight month to 6.07% in February of 2022, the highest since June of 2021 4-The Indian rupee weakened towards 76.6, not far from it's all-time low of 77.1 hit earlier in the month, 5-India kept its interest rate at a record low of 4% since March 2020 to support economic recovery from the pandemic. 6 -Investors focused on the Russia-Ukraine war and the Federal Reserve’s decision on interest rates. 7- yield hits 2.14% — its highest point since July 2019
NSE:NIFTYShort
by manojshinde27
CIPLA LONG About Cipla Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 83,510.86 Crore) operating in Pharmaceuticals sector. Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Royalty Income and Scrap for the year ending 31-Mar-2021. For the quarter ended 31-12-2021, the company has reported a Consolidated Total Income of Rs 5,570.15 Crore, down .18 % from last quarter Total Income of Rs 5,580.47 Crore and up 5.98 % from last year same quarter Total Income of Rs 5,255.63 Crore. Company has reported net profit after tax of Rs 758.95 Crore in latest quarter. The company’s top management includes Dr.Y K Hamied, Ms.Punita Lal, Mr.Adil Zainulbhai, Dr.Peter Mugyenyi, Mr.Robert Stewart, Mr.P R Ramesh, Mr.Ashok Sinha, Mr.S Radhakrishnan, Mr.Umang Vohra, Ms.Samina Hamied, Mr.M K Hamied, Ms.Naina Lal Kidwai. Company has Walker Chandiok & Co. LLP as its auditors. As on 31-12-2021, the company has a total of 80.68 Crore shares outstanding.
NSE:CIPLALong
by Unknown_Learner